| TMPDF represents the views of UK
industry in both IP right policy and practice matters
within the EU, the UK and internationally. It believes
that a cost effective, high quality IP right framework
is a critical component in industry's present and future
successes in the global economy.
All industrial and commercial companies use or are
affected by intellectual property rights and competition
law. The work of the Federation is to ensure that proper
rights are available, that these can be secured in a
straightforward and efficient way and can be litigated
without undue complexity and expense. The Federation is
very active in pursuing these needs and is of value to
all companies, of whatever size, which own IP rights.
[Even where the acquisition of rights are contracted
out, it is still important for companies within industry
to take a direct interest in the policy background.]
The Federation's aim is to bring about improvements to
intellectual property rights system throughout the
world, to the advantage not only to industry, but in
advancement of economic development generally.
TMPDF members in 2007 are:
AstraZeneca plc; Babcock International Ltd; BAE
Systems plc; BP p.l.c.; British Telecommunications
plc;British-American Tobacco Co Ltd; BTG plc; Dow Corning Ltd; Dyson Ltd; Eaton BV;
ExxonMobil Chemical Ltd; Ford of Europe; Fujitsu
Services Ltd; G E Healthcare; GlaxoSmithKline plc; GKN
plc; Hewlett-Packard Ltd; IBM UK Ltd; Imperial Chemical
Industries Plc; Infineum UK Ltd; Kodak Ltd; Merck Sharp
& Dohme Ltd; Microsoft Ltd; Nestlé UK Ltd; NXP
Semiconductors plc; Nokia UK Ltd;
Pfizer Ltd; Philips Electronics UK Ltd; Pilkington plc;
Procter & Gamble Ltd; QinetiQ Ltd; Rohm and Haas (UK) Ltd; Rolls-Royce plc; Shell
International Ltd; Sony UK Ltd; Syngenta Ltd; The BOC
Group plc; UCB Celltech Ltd; Unilever plc; Wyeth
Pharmaceuticals; Xerox Ltd. |
